Trial intelligence / Profile preview

Investigation of Brain Mechanisms Involved in Urgency Urinary Incontinence

NCT04227184Phase 4Completed

Start
Feb 2020
Primary completion
Feb 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of trospium in urge incontinence (2 arms). Primary endpoint: Responder Status at 24 weeks. Started Feb 2020; status: completed.

02

Drugs

trospium
03

Conditions

urge incontinence

Beyond the preview

Go deeper on NCT04227184.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04227184.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call